Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Buy
27,592
+1,830
+7% +$226K 0.85% 41
2025
Q4
$3.24M Sell
25,762
-19,920
-44% -$2.6M 0.81% 41
2025
Q3
$6.68M Buy
45,682
+4,443
+11% +$672K 1.62% 20
2025
Q2
$6.43M Buy
41,239
+20,268
+97% +$3.21M 1.6% 19
2025
Q1
$3.45M Buy
+20,971
New +$3.49M 0.92% 38

Other funds holding ZTS

Davis Rea's ZTS Position: Q1 2026 in Review

Davis Rea increased its Zoetis (ZTS) stake by 7.1% in Q1 2026, buying an estimated $226K and bringing the position to 27,592 shares worth $3.26M. The position accounts for 0.85% of the portfolio, ranked #41.

Davis Rea first reported a position in ZTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $6.68M in Q3 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Davis Rea held 27,592 shares of Zoetis worth $3.26M as of Q1 2026.
  • Davis Rea bought 1,830 Zoetis shares in Q1 2026, an estimated $226K.
  • Zoetis made up 0.85% of Davis Rea's portfolio in Q1 2026, its #41 holding.
  • Davis Rea first reported a position in Zoetis in Q1 2025 and has held it in 5 quarters since.
  • Davis Rea's Zoetis position peaked at $6.68M in Q3 2025.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Davis Rea's 13F filing for Q1 2026, filed 30 Apr 2026.